Sun Pharma Share Price Jumps 5% On Signing Licence Agreement With AstraZeneca

Shares of Sun Pharmaceutical Industries and AstraZeneca Pharma added 5 percent and 2 percent respectively on November 5 after both companied entered in to licensing agreement.

Sun Pharmaceutical Industries and AstraZeneca UK Ltd. entered into a licensing agreement to introduce certain novel ready to-use infusion oncology products in China, as per Sun Pharma BSE release. The agreement will help to bring cost effective and quality drugs to patients in China.

As per the terms of the agreement, Sun Pharma will be responsible for development, regulatory filings and manufacturing the products covered in the agreement while AstraZeneca will exclusively promote and distribute these products in China.

For more information ✆ +91- 6232578593 or visit www.moneymarketmanthan.com